Original Research
Accepted on 17 May 2024
Research hotspots and emerging trends of mesenchymal stem cells in cardiovascular diseases: A bibliometric-based visual analysis
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1394453
Volumes
603 Publications
Original Research
Accepted on 17 May 2024
Depletion of follicular B cell-derived antibody secreting cells does not attenuate angiotensin II-induced hypertension or vascular compliance
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1419958
Case Report
Accepted on 17 May 2024
Primary Malignant Mesothelioma of the Left Atrium Misdiagnosed as Myxoma: A Case Report
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1398311
Original Research
Published on 17 May 2024
Prognostic significance of compliance with fractional flow reserve guidance on diverse vessel-related clinical outcomes
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1370345
- 115 views
Case Report
Published on 17 May 2024
Case Report: Assessment of primary myxofibrosarcoma in the left atrium using multimodal ultrasonography
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1378655
- 112 views
Original Research
Published on 17 May 2024
Characteristics and prognostic value of cardiac magnetic resonance strain analysis in patients with different phenotypes of heart failure
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1366702
- 127 views
Original Research
Published on 17 May 2024
Association between aspirin and mortality in critically ill patients with atrial fibrillation: a retrospective cohort study based on mimic-IV database
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1280149
Original Research
Published on 17 May 2024
Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortium
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1275907
- 118 views
Original Research
Published on 17 May 2024
Knowledge and attitude toward postoperative antithrombotic management and prevention in patients with coronary revascularization: a cross-sectional study
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1388164
Original Research
Accepted on 16 May 2024
A Mendelian Randomization Study of the Effect of Mental disorders on Cardiovascular Disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1329463
Hypothesis and Theory
Accepted on 16 May 2024
A novel degradable PEG superparamagnetic iron oxide capsule coupled with a polyphenolic nano-enzymatic conjugate (PSPM-NE), to treat ROS-driven cardiovascular-diseases
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1125571
- 109 views
Review
Accepted on 16 May 2024
Leadless and Left Bundle Branch Area Pacemakers, Complementary Advantages Require a Personalized Approach
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1373884
Editorial
Accepted on 16 May 2024
Editorial: Biomarkers predicting outcomes in patients with coronary artery disease
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1432580
Original Research
Accepted on 16 May 2024
Loss of protein phosphatase 2A regulatory subunit PPP2R5A is associated with increased incidence of stress-induced proarrhythmia
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1419597
Systematic Review
Accepted on 16 May 2024
Harnessing the Power of Artificial Intelligence in Predicting All-Cause Mortality in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1343210
Original Research
Published on 16 May 2024
Sodium-glucose cotransporter 2 inhibitor dapagliflozin prevents ejection fraction reduction, reduces myocardial and renal NF-κB expression and systemic pro-inflammatory biomarkers in models of short-term doxorubicin cardiotoxicity
Frontiers in Cardiovascular Medicine
doi 10.3389/fcvm.2024.1289663
- 210 views